At Vidiia, our mission is to transition groundbreaking research into practical applications. We are thrilled to announce our partnership with the ARREST-AMR network, a consortium that shares our commitment to transforming research into real-world diagnostic solutions. This synergy strengthens our collective efforts to address the pressing challenge of AMR.  

About ARREST-AMR 

The ARREST-AMR (Accurate, Rapid, Robust, Economical One Health Diagnostics for Antimicrobial Resistance) network aims to transition groundbreaking AMR diagnostics research into practical applications. This initiative is crucial in addressing the urgent and growing threat of AMR, which jeopardises human health, animal health, agriculture, and the environment. 

Five Key Objectives of ARREST-AMR: 

Identifying Priority AMR Diagnostic Needs: 

• Assessing and pinpointing critical diagnostic needs across human health, animal health, agriculture, and environmental sectors. 

Developing Research and Innovation: 

• Leveraging cutting-edge research and technological innovation to meet these diagnostic needs effectively. 

Standardising Performance and Economic Evaluations: 

• Establishing robust performance standards and conducting economic evaluations tailored to each sector. 

Supporting Implementation: 

• Facilitating the practical implementation of diagnostics solutions across various settings. 

Cross-pollinating Best Practices: 

• Promoting the exchange of best practices and applications to ensure comprehensive and cohesive AMR strategies. 

A Message from Dr. Seshasailam Venkateswaran 

"We are grateful for the contributions of world-leading AMR experts from across the UK in shaping ARREST-AMR. By uniting varied expertise and resources, our network is set to make significant strides in the fight against AMR, advancing diagnostics from the lab to real-world applications. We look forward to collaborating with other AMR efforts across the UK and beyond." 

Dr. Seshasailam Venkateswaran (PHURI), ARREST-AMR Network Coordinator and Architect 

Vidiia’s Role in the Consortium 

At Vidiia, we bring our expertise in advanced diagnostic technologies to the ARREST-AMR consortium. Our commitment is to innovate and develop diagnostic tools that are not only accurate and rapid but also robust and economical. By collaborating with other esteemed members of the network, including academia, industry, government, regulatory agencies, and charities, we aim to foster a synergistic environment where impactful solutions to AMR can flourish. 

Looking Ahead 

Joining the ARREST-AMR consortium represents a significant step forward in Vidiia's mission to combat antimicrobial resistance. We are excited to contribute to this vital initiative and look forward to the breakthroughs and advancements that our collective efforts will achieve.